Thats fair, I wouldn't make the jump that this is a "windfall" for the directors. It is definitely well earned. Just a concern that such a high proportion of shares was sold. To me it shows a lack of confidence in the companies future.Thats true. I don't know if that makes a difference in the math though.
- Forums
- ASX - By Stock
- BOE
- Directors selling
Directors selling, page-55
Featured News
Add BOE (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.04 |
Change
0.055(1.85%) |
Mkt cap ! $1.247B |
Open | High | Low | Value | Volume |
$3.05 | $3.13 | $3.02 | $8.149M | 2.657M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
35 | 41064 | $3.03 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.04 | 11406 | 15 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
31 | 28676 | 3.030 |
22 | 55017 | 3.020 |
14 | 56807 | 3.010 |
17 | 207387 | 3.000 |
6 | 18112 | 2.990 |
Price($) | Vol. | No. |
---|---|---|
3.040 | 12608 | 23 |
3.050 | 24742 | 20 |
3.060 | 37001 | 19 |
3.070 | 47788 | 14 |
3.080 | 50060 | 10 |
Last trade - 14.22pm 13/11/2024 (20 minute delay) ? |
Featured News
BOE (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online